Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Submitted by
admin
on November 18, 2011 - 11:42am
Source:
Seeking Alpha
News Tags:
Intellipharmaceutics
generics
Pfizer
AstraZeneca
Novartis
Bristol-Myers Squibb
Headline:
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Do Not Allow Advertisers to Use My Personal information
